Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: Review and recommendations of the supportive task group of the Italian Association of Radiation Oncology

Cancer Treatment Reviews

Volumn 38, Issue 8, 2012, Pages 1033-1049

  Russi, Elvio G ^a   Corvò, Renzo ^b   Merlotti, Anna ^c   Alterio, Daniela ^d   Franco, Pierfrancesco ^e   Pergolizzi, Stefano ^f   De Sanctis, Vitaliana ^g   Ruo Redda, Maria Grazia ^h   Ricardi, Umberto ^h   Paiar, Fabiola ⁱ   Bonomo, Pierluigi ⁱ   Merlano, Marco C ^j   Zurlo, Valeria ^d   Chiesa, Fausto ^d   Sanguineti, Giuseppe ^k   Bernier, Jacques ^l  

^a Radiation Oncology Department   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Radiation Oncology Department   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e Ospedale Regionale U Parini   (Italy)

^f UNIVERSITY OF MESSINA   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j AO S Croce e Carle   (Italy)

^k Ospedale Sacro Cuore Don Calabria   (Italy)

^l CLINIQUE DE GENOLIER   (Switzerland)

more..

Author keywords

Aspiration; Chemoradiation; Dysphagia; Head and neck cancer; Radiation oncology; Swallowing dysfunction

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVERSE OUTCOME; CANCER RADIOTHERAPY; FLUOROSCOPY; HEAD AND NECK CANCER; HUMAN; MULTIMODALITY CANCER THERAPY; OPITZ SYNDROME; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE;

DEGLUTITION DISORDERS; HEAD AND NECK NEOPLASMS; HUMANS; RADIATION ONCOLOGY;

EID: 84867138628     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2012.04.002     Document Type: Review

References (196)

1. Pikus L., Levine M.S., Yang Y.-X., et al. Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. Am J Roentgenol 2003, 180(6):1613-1616.
2. van der Molen L., van Rossum M., Ackerstaff A., et al. Pretreatment organ function in patients with advanced head and neck cancer: clinical outcome measures and patients' views. BMC Ear Nose Throat Disorders 2009, 9(1):10.
3. Pauloski B.R., Rademaker A.W., Logemann J.A., et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck 2000, 22(5):474-482.
4. Simental A.A., Carrau R.L. Assessment of swallowing function in patients with head and neck cancer. Curr Oncol Rep 2004, 6(2):162-165.
5. Dysphagia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO), Raber-Durlacher J.E., Brennan M.T., et al. Swallowing dysfunction in cancer patients. Support Care Cancer 2011, 20(3):433-443.
6. Pignon J.-P., le Maître A., Maillard E., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009, 92(1):4-14.
7. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006, 368(9538):843-854.
8. Corvò R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 2007, 85(1):156-170.
9. Numico G., Russi E.G., Vitiello R., et al. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule. Int J Radiat Oncol Biol Phys 2006, 66(3):731-737.
10. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 2004, 60(5):1425-1439.
11. Robbins K.T. Barriers to winning the battle with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002, 53(1):4-5.
12. Nguyen N.P., Frank C., Moltz C.C., et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005, 61(3):772-778.
13. Langendijk J.A., Doornaert P., Verdonck-de Leeuw I.M., et al. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 2008, 26(22):3770-3776.
14. Anon. CEBM - Oxford Centre for Evidence-based Medicine - Levels of Evidence (March 2009). 2011 [accessed 03.12.11]. http://www.cebm.net/index.aspx?o=1025.
15. Martin R.E., Goodyear B.G., Gati J.S., Menon R.S. Cerebral cortical representation of automatic and volitional swallowing in humans. J Neurophysiol 2001, 85(2):938-950.
16. Rosenthal D.I., Lewin J.S., Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. JCO 2006, 24(17):2636-2643.
17. Paulsen F. Sobotta atlas of anatomy, head, neck and neuroanatomy, vol. 3. 15th revised ed. Churchill Livingstone; 2011 [online access].
18. Christianen M.E.M.C., Langendijk J.A., Westerlaan H.E., van de Water T.A., Bijl H.P. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol 2011, 101(3):394-402.
19. Schwartz D.L., Hutcheson K., Barringer D., et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010, 78(5):1356-1365.
20. Sanguineti G., Endres E.J., Gunn B.G., Parker B. Is there a 'mucosa-sparing' benefit of IMRT for head-and-neck cancer?. Int J Radiat Oncol Biol Phys 2006, 66(3):931-938.
21. Sanguineti G., Gunn G.B., Parker B.C., et al. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011, 79(1):52-59.
22. Lear C.S., Flanagan J.B., Moorrees C.F. The frequency of deglutition in man. Arch Oral Biol 1965, 10:83-100.
23. Logemann J.A., Pauloski B.R., Rademaker A.W., et al. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 2008, 30(2):148-158.
24. Eisbruch A., Lyden T., Bradford C.R., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002, 53(1):23-28.
25. Marik P.E. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001, 344(9):665-671.
26. Murphy B.A. Approaches to supportive care. Head and neck cancer: multimodality management 2011, 255-266. Springer. J. Bernier (Ed.).
27. Roe JWG, Carding PN, Rhys-Evans PH, et al. Assessment and management of dysphagia in patients with head and neck cancer who receive radiotherapy in the United Kingdom - a web-based survey. Oral Oncol 2011. 2011 [accessed 08.12.11]. http://www.sciencedirect.com/science/article/pii/S1368837511008827.
28. Speyer R., Baijens L., Heijnen M., Zwijnenberg I. Effects of therapy in oropharyngeal dysphagia by speech and language therapists: a systematic review. Dysphagia 2009, 25(1):40-65.
29. Wakasugi Y., Tohara H., Hattori F., et al. Screening test for silent aspiration at the bedside. Dysphagia 2008, 23(4):364-370.
30. Bours G.J.J.W., Speyer R., Lemmens J., Limburg M., De Wit R. Bedside screening tests vs. videofluoroscopy or fibreoptic endoscopic evaluation of swallowing to detect dysphagia in patients with neurological disorders: systematic review. J Adv Nurs 2009, 65(3):477-493.
31. Logemann J.A., Veis S., Colangelo L. A screening procedure for oropharyngeal dysphagia. Dysphagia 1999, 14(1):44-51.
32. Mari F., Matei M., Ceravolo M.G., et al. Predictive value of clinical indices in detecting aspiration in patients with neurological disorders. J Neurol Neurosurg Psychiatry 1997, 63(4):456-460.
33. Chong M.S., Lieu P.K., Sitoh Y.Y., Meng Y.Y., Leow L.P. Bedside clinical methods useful as screening test for aspiration in elderly patients with recent and previous strokes. Ann Acad Med Singapore 2003, 32(6):790-794.
34. Lim S.H., Lieu P.K., Phua S.Y., et al. Accuracy of bedside clinical methods compared with fiberoptic endoscopic examination of swallowing (FEES) in determining the risk of aspiration in acute stroke patients. Dysphagia 2001, 16(1):1-6.
35. McCullough G., Wertz R., Rosenbek J. Sensitivity and specificity of clinical/bedside examination signs for detecting aspiration in adults subsequent to stroke. J Commun Disord 2001, 34(1-2):55-72.
36. Smith R.V., Kotz T., Beitler J.J., Wadler S. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg 2000, 126(3):384-389.
37. Colodny N. Effects of age, gender, disease, and multisystem involvement on oxygen saturation levels in dysphagic persons. Dysphagia 2001, 16(1):48-57.
38. Aviv J.E. Prospective, randomized outcome study of endoscopy versus modified barium swallow in patients with dysphagia. Laryngoscope 2000, 110(4):563-574.
39. Aviv J.E., Spitzer J., Cohen M., et al. Laryngeal adductor reflex and pharyngeal squeeze as predictors of laryngeal penetration and aspiration. Laryngoscope 2002, 112(2):338-341.
40. Langmore S.E. Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior?. Curr Opin Otolaryngol Head Neck Surg 2003, 11(6):485-489.
41. Aviv J.E., Murry T., Zschommler A., Cohen M., Gartner C. Flexible endoscopic evaluation of swallowing with sensory testing: patient characteristics and analysis of safety in 1340 consecutive examinations. Ann Otol Rhinol Laryngol 2005, 114(3):173-176.
42. Murry T, Carrau RL, editors. Evaluation of dysphagia. In: Clinical management of swallowing disorders. 2nd ed. San Diego, CA: Plural Publishing; 2006. p. 95.
43. Lefebvre J.-L., Ang K.K. Larynx preservation clinical trial design: key issues and recommendations - a consensus panel summary. Int J Radiat Oncol Biol Phys 2009, 73(5):1293-1303.
44. Rademaker A.W., Pauloski B.R., Logemann J.A., Shanahan T.K. Oropharyngeal swallow efficiency as a representative measure of swallowing function. J Speech Hear Res 1994, 37(2):314-325.
45. Stenson K.M., MacCracken E., List M., et al. Swallowing function in patients with head and neck cancer prior to treatment. Arch Otolaryngol Head Neck Surg 2000, 126(3):371-377.
46. Karnell M., MacCracken E. A database information storage and reporting system for videofluorographic oropharyngeal motility (OPM) swallowing evaluations. Am J Speech Lang Pathol 1994, 3:54-60.
47. Rosenbek J.C., Robbins J.A., Roecker E.B., Coyle J.L., Wood J.L. A penetration-aspiration scale. Dysphagia 1996, 11(2):93-98.
48. Jensen K., Bonde Jensen A., Grau C. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol 2006, 78(3):298-305.
49. Pauloski B.R., Rademaker A.W., Logemann J.A., et al. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 2002, 24(6):555-565.
50. Gluck I., Feng F.Y., Lyden T., et al. Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010, 77(3):727-733.
51. Goguen L.A., Posner M.R., Norris C.M., et al. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 2006, 134(6):916-922.
52. List M.A., Siston A., Haraf D., et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 1999, 17(3):1020-1028.
53. Teguh D.N., Levendag P.C., Noever I., et al. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 2008, 72(4):1119-1127.
54. Christianen MEMC, Schilstra C, Beetz I, et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2011 [accessed 09.12.11]. http://www.sciencedirect.com/science/article/pii/S0167814011004592.
55. Patterson J., Wilson J.A. The clinical value of dysphagia preassessment in the management of head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg 2011, 19(3):177-181.
56. Langerman A., MacCracken E., Kasza K., et al. Aspiration in chemoradiated patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2007, 133(12):1289-1295.
57. Dirix P., Abbeel S., Vanstraelen B., Hermans R., Nuyts S. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2009, 75(2):385-392.
58. Langendijk J.A., Doornaert P., Rietveld D.H.F., et al. A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol 2009, 90(2):189-195.
59. Koiwai K., Shikama N., Sasaki S., Shinoda A., Kadoya M. Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancers. Radiother Oncol 2010, 97(1):132-135.
60. Hirano M., Kuroiwa Y., Tanaka S., et al. Dysphagia following various degrees of surgical resection for oral cancer. Ann Otol Rhinol Laryngol 1992, 101(2, Pt. 1):138-141.
61. Teichgraeber J., Bowman J., Goepfert H. New test series for the functional evaluation of oral cavity cancer. Head Neck Surg 1985, 8(1):9-20.
62. McConnel F.M., Pauloski B.R., Logemann J.A., et al. Functional results of primary closure vs flaps in oropharyngeal reconstruction: a prospective study of speech and swallowing. Arch Otolaryngol Head Neck Surg 1998, 124(6):625-630.
63. Logemann J.A., Bytell D.E. Swallowing disorders in three types of head and neck surgical patients. Cancer 1979, 44(3):1095-1105.
64. Pauloski B.R., Logemann J.A., Rademaker A.W., et al. Speech and swallowing function after anterior tongue and floor of mouth resection with distal flap reconstruction. J Speech Hear Res 1993, 36(2):267-276.
65. Logemann J.A., Pauloski B.R., Rademaker A.W., et al. Speech and swallow function after tonsil/base of tongue resection with primary closure. J Speech Hear Res 1993, 36(5):918-926.
66. Mcconnel F.M.S., Logemann J.A., Rademaker A.W., et al. Surgical variables affecting postoperative swallowing efficiency in oral cancer patients: a pilot study. Laryngoscope 1994, 104(1):87-90.
67. Zuydam A.C., Lowe D., Brown J.S., Vaughan E.D., Rogers S.N. Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clin Otolaryngol 2005, 30(5):428-437.
68. Kimata Y., Sakuraba M., Hishinuma S., et al. Analysis of the relations between the shape of the reconstructed tongue and postoperative functions after subtotal or total glossectomy. Laryngoscope 2003, 113(5):905-909.
69. Hartl D.M., Ferlito A., Silver C.E., et al. Minimally invasive techniques for head and neck malignancies: current indications, outcomes and future directions. Eur Arch Otorhinolaryngol 2011, 268(9):1249-1257.
70. Grant D.G., Salassa J.R., Hinni M.L., Pearson B.W., Perry W.C. Carcinoma of the tongue base treated by transoral laser microsurgery: Part 1. untreated tumors, a prospective analysis of oncologic and functional outcomes. Laryngoscope 2006, 116(12):2150-2155.
71. Hans S, Delas B, Gorphe P, Ménard M, Brasnu D. Transoral robotic surgery in head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis. 2012 [accessed 21.01.12]. http://www.sciencedirect.com/science/article/pii/S187972961100127X.
72. O'Malley B.W., Weinstein G.S., Snyder W., Hockstein N.G. Transoral robotic surgery (TORS) for base of tongue neoplasms. Laryngoscope 2006, 116(8):1465-1472.
73. Mukhija V.K., Sung C.-K., Desai S.C., Wanna G., Genden E.M. Transoral robotic assisted free flap reconstruction. Otolaryngol Head Neck Surg 2009, 140(1):124-125.
74. Selber J.C., Robb G., Serletti J.M., et al. Transoral robotic free flap reconstruction of oropharyngeal defects: a preclinical investigation. Plast Reconstr Surg 2010, 125(3):896-900.
75. Kronenberger M.B., Meyers A.D. Dysphagia following head and neck cancer surgery. Dysphagia 1994, 9(4):236-244.
76. Urken M.L., Buchbinder D., Weinberg H., et al. Functional evaluation following microvascular oromandibular reconstruction of the oral cancer patient: a comparative study of reconstructed and nonreconstructed patients. Laryngoscope 1991, 101(9):935-950.
77. Mehta R.P., Deschler D.G. Mandibular reconstruction in 2004: an analysis of different techniques. Curr Opin Otolaryngol Head Neck Surg 2004, 12(4):288-293.
78. Vos J.D., Burkey B.B. Functional outcomes after free flap reconstruction of the upper aerodigestive tract. Curr Opin Otolaryngol Head Neck Surg 2004, 12(4):305-310.
79. Miles B.A., Goldstein D.P., Gilbert R.W., Gullane P.J. Mandible reconstruction. Curr Opin Otolaryngol Head Neck Surg 2010, 18(4):317-322.
80. Manikantan K., Khode S., Sayed S.I., et al. Dysphagia in head and neck cancer. Cancer Treat Rev 2009, 35(8):724-732.
81. Boyd J.B., Gullane P.J., Rotstein L.E., Brown D.H., Irish J.C. Classification of mandibular defects. Plast Reconstr Surg 1993, 92(7):1266-1275.
82. Gullane P.J. Primary mandibular reconstruction: analysis of 64 cases and evaluation of interface radiation dosimetry on bridging plates. Laryngoscope 1991, 101(6):1-24.
83. Plant R.L. Anatomy and physiology of swallowing in adults and geriatrics. Otolaryngol Clin North Am 1998, 31(3):477-488.
84. Yoshikawa M., Yoshida M., Nagasaki T., et al. Influence of aging and denture use on liquid swallowing in healthy dentulous and edentulous older people. J Am Geriatr Soc 2006, 54(3):444-449.
85. Wells M.D., Luce E.A. Reconstruction of midfacial defects after surgical resection of malignancies. Clin Plast Surg 1995, 22(1):79-89.
86. Brown K.E. Peripheral consideration in improving obturator retention. J Prosthet Dent 1968, 20(2):176-181.
87. Triana R.J., Uglesic V., Virag M., et al. Microvascular free flap reconstructive options in patients with partial and total maxillectomy defects. Arch Facial Plast Surg 2000, 2(2):91-101.
88. Browne J.D., Butler S., Rees C. Functional outcomes and suitability of the temporalis myofascial flap for palatal and maxillary reconstruction after oncologic resection. Laryngoscope 2011, 121(6):1149-1159.
89. Hurst P.S. The role of the prosthodontist in the correction of swallowing disorders. Otolaryngol Clin North Am 1988, 21(4):771-781.
90. Brown J.S., Rogers S.N., Lowe D. A comparison of tongue and soft palate squamous cell carcinoma treated by primary surgery in terms of survival and quality of life outcomes. Int J Oral Maxillofac Surg 2006, 35(3):208-214.
91. Labayle J., Bismuth R. Total laryngectomy with reconstitution. Ann Otolaryngol Chir Cervicofac 1971, 88(4):219-228.
92. Rizzotto G., Succo G., Lucioni M., Pazzaia T. Subtotal laryngectomy with tracheohyoidopexy: a possible alternative to total laryngectomy. Laryngoscope 2006, 116(10):1907-1917.
93. Piquet JJ, Chevalier D, Lacau-StGuily J. Aprés exérèse horizontale glottique, sus-glottique, glosso-sus-glottique et hémipharyngolaryngée. In: Traissac L, editors. Réhabilitation de la voix et de la déglutition après chirurgie partielle ou totale du larynx. Socièté Française d'Oto-Rhino-Laryngologie et de Pathologie Cervico-Faciale. Paris: Arentte; 1992. p. 173-92.
94. Logemann J.A., Gibbons P., Rademaker A.W., et al. Mechanisms of recovery of swallow after supraglottic laryngectomy. J Speech Hear Res 1994, 37(5):965-974.
95. Lewin J.S., Hutcheson K.A., Barringer D.A., et al. Functional analysis of swallowing outcomes after supracricoid partial laryngectomy. Head Neck 2008, 30(5):559-566.
96. Lazarus C.L., Logemann J.A., Pauloski B.R., et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996, 106(9, Pt. 1):1157-1166.
97. Piquet J.J., Desaulty A., Decroix G. Crico-hyoido-epiglotto-pexy. Surgical technic and functional results. Ann Otolaryngol Chir Cervicofac 1974, 91(12):681-686.
98. Ding R., Logemann J.A. Swallow physiology in patients with trach cuff inflated or deflated: a retrospective study. Head Neck 2005, 27(9):809-813.
99. Balfe D.M., Koehler R.E., Setzen M., et al. Barium examination of the esophagus after total laryngectomy. Radiology 1982, 143(2):501-508.
100. Nash M. Swallowing problems in the tracheotomized patient. Otolaryngol Clin North Am 1988, 21(4):701-709.
101. Leder S.B., Ross D.A. Confirmation of no causal relationship between tracheotomy and aspiration status: a direct replication study. Dysphagia 2009, 25(1):35-39.
102. Levine T.M. Swallowing disorders following skull base surgery. Otolaryngol Clin North Am 1988, 21(4):751-759.
103. Jennings K.S., Siroky D., Jackson C.G. Swallowing problems after excision of tumors of the skull base: diagnosis and management in 12 patients. Dysphagia 1992, 7(1):40-44.
104. Nuyts S., Dirix P., Clement P.M.J., et al. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2009, 73(4):1088-1095.
105. Langmore S.E., Krisciunas G.P. Dysphagia after radiotherapy for head and neck cancer: etiology, clinical presentation, and efficacy of current treatments. Perspect Swallow Swallow Disord (Dysphagia) 2010, 19(2):32-38.
106. Gramley F., Lorenzen J., Koellensperger E., et al. Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway. Int J Cardiol 2010, 143(3):405-413.
107. Haydont V., Riser B.L., Aigueperse J., Vozenin-Brotons M.-C. Specific signals involved in the long-term maintenance of radiation-induced fibrogenic differentiation: a role for CCN2 and low concentration of TGF-β1. Am J Physiol Cell Physiol 2008, 294(6):C1332-C1341.
108. Ask K., Bonniaud P., Maass K., et al. Progressive pulmonary fibrosis is mediated by TGF-β isoform 1 but not TGF-β3. Int J Biochem Cell Biol 2008, 40(3):484-495.
109. Okunieff P., Chen Y., Maguire D.J., Huser A.K. Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev 2008, 27(3):363-374.
110. Rødningen O.K., Børresen-Dale A.-L., Alsner J., Hastie T., Overgaard J. Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. Radiother Oncol 2008, 86(3):314-320.
111. Bourgier C., Haydont V., Milliat F., et al. Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. Gut 2005, 54(3):336-343.
112. Gervaz P., Morel P., Vozenin-Brotons M.-C. Molecular aspects of intestinal radiation-induced fibrosis. Curr Mol Med 2009, 9(3):273-280.
113. Pohlers D., Brenmoehl J., Löffler I., et al. TGF-β and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta Mol Basis Dis 2009, 1792(8):746-756.
114. Denham J.W., Hauer-Jensen M., Peters L.J. Is it time for a new formalism to categorize normal tissue radiation injury?. Int J Radiat Oncol Biol Phys 2001, 50(5):1105-1106.
115. Popovtzer A., Cao Y., Feng F.Y., Eisbruch A. Anatomical changes in the pharyngeal constrictors after chemoirradiation of head and neck cancer and their dose-effect relationships: MRI-based study. Radiother Oncol 2009, 93(3):510-515.
116. Liu R.-M., Gaston Pravia K.A. Oxidative stress and glutathione in TGF-β-mediated fibrogenesis. Free Radic Biol Med 2010, 48(1):1-15.
117. Lazarus C., Logemann J.A., Pauloski B.R., et al. Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. Head Neck 2007, 29(7):632-637.
118. Wu C.H., Hsiao T.Y., Ko J.Y., Hsu M.M. Dysphagia after radiotherapy: endoscopic examination of swallowing in patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000, 109(3):320-325.
119. Jensen K., Lambertsen K., Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007, 85(1):74-82.
120. Feng F.Y., Kim H.M., Lyden T.H., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007, 68(5):1289-1298.
121. Kendall K.A., McKenzie S.W., Leonard R.J., Jones C. Structural mobility in deglutition after single modality treatment of head and neck carcinomas with radiotherapy. Head Neck 1998, 20(8):720-725.
122. Kendall K.A., McKenzie S.W., Leonard R.J., Jones C.U. Timing of swallowing events after single-modality treatment of head and neck carcinomas with radiotherapy. Ann Otol Rhinol Laryngol 2000, 109(8, Pt. 1):767-775.
123. Eisbruch A. Dysphagia and aspiration following chemo-irradiation of head and neck cancer: major obstacles to intensification of therapy. Ann Oncol 2004, 15(3):363-364.
124. Nguyen N.P., Moltz C.C., Frank C., et al. Impact of swallowing therapy on aspiration rate following treatment for locally advanced head and neck cancer. Oral Oncol 2007, 43(4):352-357.
125. Yoshikawa M., Yoshida M., Nagasaki T., et al. Aspects of swallowing in healthy dentate elderly persons older than 80 years. J Gerontol A Biol Sci Med Sci 2005, 60(4):506-509.
126. Taylor J.M., Mendenhall W.M., Lavey R.S. Dose, time, and fraction size issues for late effects in head and neck cancers. Int J Radiat Oncol Biol Phys 1992, 22(1):3-11.
127. Mekhail T.M., et al. Enteral nutrition during the treatment of head and neck carcinoma. Cancer 2001, 91(9):1785-1790.
128. Beer K.T., Krause K.B., Zuercher T., Stanga Z. Early percutaneous endoscopic gastrostomy insertion maintains nutritional state in patients with aerodigestive tract cancer. Nutr Cancer 2005, 52(1):29-34.
129. Locher J.L., Bonner J.A., Carroll W.R., et al. Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer. J Parenter Enteral Nutr 2011, 35(3):365-374.
130. Nugent B, Lewis S, O'Sullivan JM. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. 2012 [accessed 21.01.12]. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007904.pub2/abstract.
131. Nguyen N.P., Moltz C.C., Frank C., et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 2004, 15(3):383-388.
132. Levendag P.C., Teguh D.N., Voet P., et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 2007, 85(1):64-73.
133. Caudell J.J., Schaner P.E., Desmond R.A., et al. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010, 76(2):403-409.
134. Caglar H.B., Tishler R.B., Othus M., et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72(4):1110-1118.
135. Peponi E., Glanzmann C., Willi B., Huber G., Studer G. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiat Oncol 2011, 6:1.
136. Li B., Li D., Lau D.H., et al. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol 2009, 4:52.
137. Teguh D.N., Levendag P.C., Sewnaik A., et al. Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx. Radiother Oncol 2008, 89(1):57-63.
138. Jackson A., Marks L.B., Bentzen S.M., et al. The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys 2010, 76(3, Suppl. 1):S155-S160.
139. Rancati T., Schwarz M., Allen A.M., et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 2010, 76(3, Suppl. 1):S64-S69.
140. Marks L.B., Yorke E.D., Jackson A., et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010, 76(3, Suppl. 1):S10-S19.
141. Pauloski B.R., Logemann J.A., Rademaker A.W., et al. Speech and swallowing function after oral and oropharyngeal resections: one-year follow-up. Head Neck 1994, 16(4):313-322.
142. Pauloski B.R., Logemann J.A. Impact of tongue base and posterior pharyngeal wall biomechanics on pharyngeal clearance in irradiated postsurgical oral and oropharyngeal cancer patients. Head Neck 2000, 22(2):120-131.
143. Murry T., Madasu R., Martin A., Robbins K.T. Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck 1998, 20(1):31-37.
144. Henk J.M. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol (R Coll Radiol) 1997, 9(5):308-312.
145. Gillespie M.B., Brodsky M.B., Day T.A., Lee F.-S., Martin-Harris B. Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 2004, 114(8):1362-1367.
146. Gillespie M.B., Brodsky M.B., Day T.A., et al. Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 2005, 131(7):615-619.
147. Lewin J.S. Dysphagia after chemoradiation: prevention and treatment. Int J Radiat Oncol Biol Phys 2007, 69(2, Suppl. 1):S86-S87.
148. Lazarus C.L., Logemann J.A., Pauloski B.R., et al. Swallowing and tongue function following treatment for oral and oropharyngeal cancer. J Speech Lang Hear Res 2000, 43(4):1011-1023.
149. Hanna E., Alexiou M., Morgan J., et al. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg 2004, 130(7):861-867.
150. Mittal B.B., Pauloski B.R., Haraf D.J., et al. Swallowing dysfunction - preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 2003, 57(5):1219-1230.
151. Matsuo K., Palmer J.B. Anatomy and physiology of feeding and swallowing - normal and abnormal. Phys Med Rehabil Clin N Am 2008, 19(4):691-707.
152. Smith H.A., Lee S.H., O'Neill P.A., Connolly M.J. The combination of bedside swallowing assessment and oxygen saturation monitoring of swallowing in acute stroke: a safe and humane screening tool. Age Ageing 2000, 29(6):495-499.
153. Rinkel R.N., Verdonck-de Leeuw I.M., Langendijk J.A., et al. The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral Oncol 2009, 45(8):e67-e71.
154. Chen A.Y., Frankowski R., Bishop-Leone J., et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson Dysphagia Inventory. Arch Otolaryngol Head Neck Surg 2001, 127(7):870-876.
155. List M.A., D'Antonio L.L., Cella D.F., et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer 1996, 77(11):2294-2301.
156. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5):365-376.
157. Bjordal K., de Graeff A., Fayers P.M., et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer 2000, 36(14):1796-1807.
158. Bjordal K., Hammerlid E., Ahlner-Elmqvist M., et al. Quality of life in head and neck cancer patients: validation of the European organization for research and treatment of cancer quality of life questionnaire-H&N35. J Clin Oncol 1999, 17(3):1008.
159. Bjordal K., Ahlner-Elmqvist M., Tollesson E., et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 1994, 33(8):879-885.
160. Cella D.F., Wiklund I., Shumaker S.A., Aaronson N.K. Integrating health-related quality of life into cross-national clinical trials. Qual Life Res 1993, 2(6):433-440.
161. Weymuller E.A., Alsarraf R., Yueh B., Deleyiannis F.W.-B., Coltrera M.D. Analysis of the performance characteristics of the University of Washington Quality of Life Instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg 2001, 127(5):489-493.
162. Funk G.F., Karnell L.H., Christensen A.J., Moran P.J., Ricks J. Comprehensive head and neck oncology health status assessment. Head Neck 2003, 25(7):561-575.
163. Terrell J.E., Nanavati K.A., Esclamado R.M., et al. Head and neck cancer-specific quality of life: instrument validation. Arch Otolaryngol Head Neck Surg 1997, 123(10):1125-1132.
164. Stiff P.J., Erder H., Bensinger W.I., et al. Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant 2006, 37(4):393-401.
165. Epstein J.B., Beaumont J.L., Gwede C.K., et al. Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer 2007, 109(9):1914-1922.
166. Murphy B.A., Dietrich M.S., Wells N., et al. Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation. Head Neck 2010, 32(1):26-37.
167. Dwivedi R.C., Rose S.S., Roe J.W.G., et al. Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients. Oral Oncol 2010, 46(4):e10-e14.
168. Anon. Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) v. 4. U.S. Department of Health and Human Services. National Institutes of Health National Cancer Institute; 2009. 2010 [accessed 10.07.10]. http://evs.nci.nih.gov/ftp1/CTCAE/About.html.
169. Anon. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). U.S. Department of Health and Human Services. National Institutes of Health National Cancer Institute; 2006. 2010 [accessed 25.06.10]. http://www.zotero.org/support/quick_start_guide.
170. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31(5):1341-1346.
171. Enderby P.M., John A. Therapy outcome measures in speech and language therapy: comparing performance between different providers. Int J Lang Commun Disord 1999, 34(4):417-429.
172. List M.A., Ritter-Sterr C., Lansky S.B. A performance status scale for head and neck cancer patients. Cancer 1990, 66(3):564-569.
173. Hughes P.J., Scott P.M., Kew J., et al. Dysphagia in treated nasopharyngeal cancer. Head Neck 2000, 22(4):393-397.
174. Rosen A., Rhee T.H., Kaufman R. Prediction of aspiration in patients with newly diagnosed untreated advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2001, 127(8):975-979.
175. Carrara-de Angelis E., Feher O., Barros A.P.B., Nishimoto I.N., Kowalski L.P. Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg 2003, 129(7):733-738.
176. Graner D.E., Foote R.L., Kasperbauer J.L., et al. Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 2003, 113(3):573-579.
177. Smith R.V., Goldman S.Y., Beitler J.J., Wadler S.S. Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130(7):831-836.
178. Kotz T., Costello R., Li Y., Posner M.R. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 2004, 26(4):365-372.
179. Nguyen N.P., Frank C., Moltz C.C., et al. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence. Radiother Oncol 2006, 80(3):302-306.
180. Feng F.Y., Kim H.M., Lyden T.H., et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 2010, 28(16):2732-2738.
181. Zuydam A.C., Rogers S.N., Brown J.S., Vaughan E.D., Magennis P. Swallowing rehabilitation after oro-pharyngeal resection for squamous cell carcinoma. Br J Oral Maxillofac Surg 2000, 38(5):513-518.
182. Fujimoto Y., Hasegawa Y., Nakayama B., Matsuura H. Usefulness and limitation of crico-pharyngeal myotomy and laryngeal suspension after wide resection of the tongue or oropharynx. Nippon Jibiinkoka Gakkai Kaiho 1998, 101(3):307-311.
183. Barbosa Furia C.L., Carrara-de Angelis E., Silva Martins N.M., et al. Video fluoroscopic evaluation after glossectomy. Arch Otolaryngol Head Neck Surg 2000, 126(3):378-383.
184. Smith Hammond C.A., Goldstein L.B. Cough and aspiration of food and liquids due to oral-pharyngeal dysphagia. Chest 2006, 129(1, Suppl.):154S-168S.
185. Dysphagia Document Review and Revision Working Group. Roles of speech-language pathologists in swallowing and feeding disorders. Rockville, MD: American Speech-Language-Hearing Association; 2002. 2011 [accessed 30.10.11]. http://www.asha.org/docs/html/PS2002-00109.html.
186. Anon. Diagnosis and treatment of swallowing disorders (dysphagia) in acute-care stroke patients - NCBI bookshelf. Washington, DC: Agency for Health Care Policy and Research (US); 1999. 2011 [accessed 08.12.11]. http://www.ncbi.nlm.nih.gov.bvs.cilea.it/books/NBK33017.
187. Tohara H., Saitoh E., Mays K.A., Kuhlemeier K., Palmer J.B. Three tests for predicting aspiration without videofluorography. Dysphagia 2003, 18:126-134.
188. Patterson J.M., McColl E., Carding P.N., Kelly C., Wilson J.A. Swallowing performance in patients with head and neck cancer: a simple clinical test. Oral Oncol 2009, 45(10):904-907.
189. Aviv J.E., Sataloff R.T., Cohen M., et al. Cost-effectiveness of two types of dysphagia care in head and neck cancer: a preliminary report. Ear Nose Throat J 2001, 80(8):553-556. 558.
190. Barringer D. Dyspahgia evaluation and treatment. What you need to know, 2008. Available from: http://www.txsha.org/_pdf/Convention/09Convention/Baringer%20Handouts/Barringer,%20Denise%20-%20Dysphagia%20Evaluation%20and%20Treatment_What%20You%20Need%20to%20Know.pdf.
191. Logemann J.A. Swallowing disorders. Best Pract Res Clin Gastroenterol 2007, 21(4):563-573.
192. Curtis D.A., Plesh O., Miller A.J., et al. A comparison of masticatory function in patients with or without reconstruction of the mandible. Head Neck 1997, 19(4):287-296.
193. Dirix P., Nuyts S. Evidence-based organ-sparing radiotherapy in head and neck cancer. Lancet Oncol 2010, 11(1):85-91.
194. Lin D.-S., Jen Y.-M., Lee J.-C., Liu S.-C., Lin Y.-S. Recurrence of nasopharyngeal carcinoma in the parotid region after parotid-gland-sparing radiotherapy. J Formos Med Assoc 2011, 110(10):655-660.
195. Cannon D.M., Lee N.Y. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008, 70(3):660-665.
196. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine, 1992. Chest 2009, 136(5, Suppl.):e28.